SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -12.5% | 230 | 0.0% | 0.01% | +150.0% |
| Q1 2022 | $8,000 | +700.0% | 230 | +721.4% | 0.00% | – |
| Q4 2021 | $1,000 | -80.0% | 28 | -75.2% | 0.00% | -100.0% |
| Q3 2021 | $5,000 | -72.2% | 113 | -65.1% | 0.00% | -75.0% |
| Q2 2021 | $18,000 | -55.0% | 324 | -39.0% | 0.00% | -60.0% |
| Q1 2021 | $40,000 | +185.7% | 531 | +236.1% | 0.01% | +233.3% |
| Q4 2020 | $14,000 | +55.6% | 158 | +1.9% | 0.00% | +50.0% |
| Q3 2020 | $9,000 | +200.0% | 155 | +101.3% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | 0.0% | 77 | -32.5% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | +200.0% | 114 | +470.0% | 0.00% | – |
| Q4 2019 | $1,000 | -93.8% | 20 | -82.6% | 0.00% | -100.0% |
| Q3 2019 | $16,000 | – | 115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |